The Pharmaceuticals and Medical Devices Agency (PMDA) has added a new project team titled “Project team for Consideration of Guiding Principles for AI Utilization.” This team is part of the agency’s “Projects Across Multi‑Offices” program and will focus on developing guiding principles for the use of artificial intelligence in pharmaceutical and medical device contexts.
Regulatory UpdatesAug 24, 2026•1 min read
PMDA Adds Project Team for AI Utilization Guiding Principles
The Pharmaceuticals and Medical Devices Agency (PMDA) announced a new project team to develop guiding principles for AI utilization, listed under its “Projects Across Multi‑Offices” initiative.
Compiled by the PharmaCountry team · Source: Pharmaceuticals and Medical Devices Agency
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating